Category: Social Selling

A full recording of the Factor Forum Webinar - What to Say When You Can't Say Anything: Discussing New Approaches to Messaging for the Field is now available to watch.

Our most recent FieldWatch Newsletter is out now! Chock full of the latest news and insights for FieldWatchers everywhere, this digital newsletter is never one to miss. Check out the Q2 edition today.

The FDA and FTC continue their crack down on COVID-19 related product claims. According to an article from The National Law Review, these two regulatory bodies have now jointly issued warning letters regarding such claims to multiple CBD companies.

Mark your calendars for Thursday, May 5 at 12 pm Central and register now for the next Factor Forum Webinar - What To Say When You Can't Say Anything: Discussing New Approaches to Messaging for the Field.

Continuing to up its enforcement game, the Federal Trade Commission (FTC) issued a proposed order to stop two companies from continuing to promote and sell supplements after using baseless health claims. While this order is not finalized and does not include any direct sellers, it is yet another regulatory action to watch.

The first 2022 edition of Momentum Factor's Social Selling Update Quarterly Newsletter is hitting inboxes today! Don't miss out on all of the professional news and insights for the direct selling executive.

Retailers had to take a more direct-to-consumer (D2C) sales approach due to the pandemic and have found success in a space previously dominated by the direct sales industry.

With no significant movement on 13(b) legislation, the FTC is now looking for new ways to hold businesses accountable for deceptive claims according to this article from Kelley Drye.

The FTC has announced a tentative agenda for its Open Commission Meeting on February 17 and one of the main topics is of particular interest to the direct selling industry. Amond other items, the commission is planning to discuss and vote on the Advanced Notice of Proposed Rulemaking Concerning Earnings Claims.

The Federal Trade Commission (FTC) issued letters today (January 19, 2022) warning more than 20 companies - including some direct sellers - to immediately stop making baseless claims regarding their products treating or preventing COVID-19.